Etiology And Pathogenesis
- Represents chronic inflammatory disease manifesting primarily in infancy and adolescence.
- Cutaneous distribution directly parallels size, distribution, and activity of sebaceous glands.
- Exact etiology remains unknown.
- Malassezia furfur (commensal yeast) heavily incriminated in disease pathogenesis.
- Cutaneous inflammation potentially results from direct fungal action, fungal by-products, or exaggerated host immune response.
- Adolescent manifestation strictly follows puberty, indicating distinct sex hormone influence.
- Relationship between infantile and adolescent forms remains unclear; infantile disease does not predict adolescent recurrence.
Clinical Manifestations
Infantile Seborrheic Dermatitis
- Onset typically occurs within first 4 weeks of life.
- Illness remains self-limiting, generally resolving by 12 weeks to 1 year of age.
- Initial manifestation frequently involves diffuse or focal scaling and crusting of scalp, clinically termed cradle cap.
- Characterized by yellow-orange, greasy scales and crusts overlying erythema.
- Lesions frequently expand to involve face, neck, retroauricular areas, axillae, umbilicus, and diaper area.
- Cutaneous lesions generally remain nonpruritic in infants.
- Postinflammatory pigmentary changes (hypopigmentation) commonly observed in darker skin tones.
- Intractable seborrhea-like dermatitis associated with chronic diarrhea and failure to thrive mandates urgent evaluation for systemic immune dysfunction.
- Chronic treatment-resistant pattern occasionally indicates underlying Langerhans cell histiocytosis.
Adolescent Seborrheic Dermatitis
- Disease onset universally follows puberty.
- Follows chronic relapsing course, generally lacking spontaneous resolution.
- Disease remains more localized, confined primarily to scalp, chest, and intertriginous areas.
- Scalp manifestations vary from diffuse brawny scaling to focal thick, oily, yellow crusts with underlying erythema.
- Frequently involves marginal blepharitis and external auditory canal inflammation.
- Severe cases exhibit prominent erythema and scaling at frontal hairline, medial eyebrows, nasolabial folds, and retroauricular folds.
- Red, scaly plaques frequently appear in axillae, inguinal region, gluteal cleft, and umbilicus.
- Extremity plaques often appear more eczematous, less erythematous, and poorly demarcated.
- Pruritus highly variable, ranging from absent to marked.
- Accompanying hair loss remains distinctly uncommon.
Associated Systemic Conditions
- Represents frequent cutaneous manifestation of Acquired Immunodeficiency Syndrome.
- Human Immunodeficiency Virus infected patients exhibit thick, greasy scalp scales and large hyperkeratotic erythematous plaques on face, chest, and genitals.
Differential Diagnosis
| Diagnostic Entity | Distinguishing Clinical Features |
|---|---|
| Atopic Dermatitis | Characterized by acute weeping, severe pruritus; often clinically indistinguishable from seborrheic dermatitis in early infancy. |
| Psoriasis | Exhibits bright red, scaly, well-demarcated plaques; highly persistent; strong family history common. |
| Langerhans Cell Histiocytosis | Presents with treatment-resistant, infiltrative, crusted, hemorrhagic papules in groin, axillae, scalp; accompanied by systemic signs including hepatosplenomegaly and anemia. |
| Candidiasis | Involves intertriginous and convex surfaces; features bright-red plaques with diagnostic satellite pustules. |
| Irritant Diaper Dermatitis | Strictly spares intertriginous creases; localized strictly to convex contact surfaces. |
Therapeutic Management Protocol
Infantile Disease Management
| Therapeutic Modality | Specific Clinical Recommendations |
|---|---|
| General Skin Care | Emollients, baby oil, gentle shampooing utilizing nonmedicated baby shampoo. |
| Mechanical Scale Removal | Pretreatment with oil followed by gentle brushing removes thick cradle cap crusts effectively. |
| Refractory Lesions | Apply 2% ketoconazole shampoo or cream twice daily. |
| Inflammatory Lesions | Short course of mild, low-potency topical corticosteroids applied once daily for 1 week. |
| Steroid Sparing Agents | Topical calcineurin inhibitors (pimecrolimus or tacrolimus) hasten clinical subsidence. |
Adolescent Disease Management
| Target Anatomical Area | Specific Pharmacologic Interventions |
|---|---|
| Scalp (First-Line Therapy) | Antifungal shampoos (selenium sulfide, ketoconazole, ciclopirox, zinc pyrithione, salicylic acid, tar) utilized several times weekly to daily. |
| Scalp (Inflamed Lesions) | Mid-potency topical corticosteroids (fluocinolone 0.01% oil or triamcinolone 0.1% lotion) applied once daily for 2-4 weeks. |
| Facial Lesions | Low-potency topical corticosteroid cream combined continuously with topical antifungals (ketoconazole 2% cream/shampoo). |
| Trunk And Extremity Lesions | Mid-potency topical corticosteroid cream combined continuously with topical antifungals. |
| Second-Line Options | Topical calcineurin inhibitors; potent keratolytic agents including urea. |
| Severe Refractory Disease | Oral antifungal agents utilized in severe adult cases; comprehensive pediatric data remains lacking. |
| Long-Term Maintenance | Antifungal shampoo utilized strictly twice-weekly significantly reduces clinical relapse risk. |